In navigating the era of cell and gene therapy, pharmaceutical firms must strategically engage stakeholders digitally while preserving space for personalized patient care amidst the digital landscape.
The integration of AI in medical affairs signifies a transformative shift, enhancing efficiency in workflows, fostering personalized patient care, and necessitating a delicate balance between innovation and regulation
Pharma companies are increasingly recognizing the potential of digital health solutions to transform the healthcare landscape, and many are looking to scale their digital initiatives globally.
To help boost patient-centricity, centralization of internal and external data allows for faster insight generation among pharmaceutical company teams.
Social determinants of health can blur the safety and efficacy profiles of therapies, making it critical for the pharmaceutical industry to find ways to ease healthcare barriers.